Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension
Clinical trial NCT02322450 · COMPLETED
Trial details
- NCT number
- NCT02322450
- Sponsor
- Quantum Genomics SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-04-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.